Showing results (931-940 of 1,006) with videos related to

Sort By:
Pageof 101
Access Microbiology|December 11, 2023
Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccinationMichael Asamoah-Boaheng, Brian Grunau, Scott Haig, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 20, 1998
Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitisE Minshall, O Ghaffar, L Cameron, et al.
Microbiology Spectrum|June 8, 2023
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021Yi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
Protein Expression and Purification|September 10, 2010
Functional comparison of recombinant acidic mammalian chitinase with enzyme from murine bronchoalveolar lavageEric R Goedken, Robert F O'Brien, Tao Xiang, et al.
JBMR Plus|March 10, 2020
Bone Mineral Is More Heterogeneously Distributed in the Femoral Heads of Osteoporotic and Diabetic Patients: A Pilot StudyEoin Parle, Sherdya Tio, Annie Behre, et al.
Transfusion|December 15, 2019
The impact of age and sex on first-time donor return behaviorBarbara M Masser, Stephen Wright, Marc Germain, et al.
Journal of Neurosurgery. Pediatrics|February 21, 2025
Optimal timing of endoscopic sagittal suturectomyPatrick F O'Brien, Saige A Teti, Callum Dewar, et al.
Microbiology Spectrum|March 7, 2022
Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273Brian Grunau, Liam Golding, Martin A Prusinkiewicz, et al.
Neurosurgical Focus|September 1, 2024
MR-guided focused ultrasound in pediatric neurosurgery: current insights, technical challenges, and lessons learned from 45 treatments at Children's National HospitalGregory F Keating, Kelsi M Chesney, Nirali Patel, et al.
British Journal of Cancer|December 15, 2015
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapantZ Zakaria, A Tivnan, L Flanagan, et al.
Pageof 101